Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ATRASENTAN HYDROCHLORIDE
- Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
- Atrasentan in Patients With Proteinuric Glomerular Diseases
- Atrasentan in Patients With IgA Nephropathy
- Atrasentan Spermatogenesis and Testicular Function
- Study Of Diabetic Nephropathy With Atrasentan
- Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
- A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
- Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled D
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
- Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma
- Correlation of Endothelial Function and Early Coronary Artery Disease in Humans
- Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
- S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
- A Long Term Safety Study With Atrasentan
- Atrasentan in Treating Patients With Prostate Cancer
- Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
- Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
- Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
- A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
- Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma
Clinical trials list
click for details